Recently, Jewell et al. reported that the overexpression of RAD52 mRNA could predict poor PFS with a hazard ratio of 4.49 in melanoma and that cancer cells with upregulated genes of DNA repair pathways were likely to be more aggressive [41]. This evidence concerns the gene RAD52 and cancer.